Guoqiang Wang

Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non–Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel

Zhijie Wang, Jianchun Duan, Shangli Cai et al. · JAMA Oncology · 2019 · 495 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Crystal Structures of the Human RNA Demethylase Alkbh5 Reveal Basis for Substrate Recognition

Chong Feng, Yang Liu, Guoqiang Wang et al. · Journal of Biological Chemistry · 2014 · 195 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

Identification of Deleterious <i>NOTCH</i> Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC

Kai Zhang, Xiaohua Hong, Zhengbo Song et al. · Clinical Cancer Research · 2020 · 137 citations

Medicine, Genetics, Oncology +17

Sirt1 AS lncRNA interacts with its mRNA to inhibit muscle formation by attenuating function of miR-34a

Guoqiang Wang, Yu Wang, Yan Xiong et al. · Scientific Reports · 2016 · 133 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Allele Frequency–Adjusted Blood-Based Tumor Mutational Burden as a Predictor of Overall Survival for Patients With NSCLC Treated With PD-(L)1 Inhibitors

Zhijie Wang, Jianchun Duan, Guoqiang Wang et al. · Journal of Thoracic Oncology · 2019 · 92 citations · Full text

Medicine, Oncology, Pharmacotherapy +13